-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Nanatinostat + Valganciclovir) in Post-Transplant Lymphoproliferative Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Nanatinostat + Valganciclovir) in Post-Transplant Lymphoproliferative Disorder Drug Details: Nana-Val is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pilocarpine in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: Pilocarpine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-278 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-278 in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-278 in Type 2 Diabetes Drug Details: AT-278 is under...